Major Force in the Curosurf (Poractant Alfa) Market 2025: Impact Of Rising Respiratory Disorders On The Growth Of The Pulmonary Surfactant Market

How Will the Curosurf (Poractant Alfa) Market Grow, and What Is the Projected Market Size?
The market size of curosurf (poractant alfa) has witnessed a health compounded annual growth rate of $XX% in the past few years. The market is expected to surge from $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of $XX%. This growth during the historical period is attributed to the heightened demand for advanced medical solutions, increased use of synthetic surfactants in sanitary products, rise in healthcare consciousness, better access to healthcare, and growing preference for convenient cleanliness which escalates the sales of synthetic surfactant, plus a spike in healthcare awareness.

Over the coming years, it is forecasted that the Curosurf (poractant alfa) market size will see an expansion with $XX. By 2029, the market will have grown to a value of $XX million with a compound annual growth rate (CAGR) of $XX%. This anticipated growth can be linked to several factors such as the rising occurrence of premature births, the increased application of synthetic surfactants in agrochemicals, the growing rate of chronic respiratory diseases, the spike in expenditure on healthcare and a growing preference for dealing with respiratory infection. Key trends during this forecasted period include the adoption of microdosing strategies, the incorporation of surfactant therapy, the use of biologic and immunomodulatory therapies, a shift towards sustainable and green surfactants, and an emphasis on neonatal and pediatric care.

What Key Elements Are Boosting Growth in the Curosurf (Poractant Alfa) Market?
A surge in respiratory problems is anticipated to stimulate the curosurf (poractant alfa) market's growth. Respiratory conditions, such as asthma, COPD, and lung cancer, are widespread and lead to impeded lungs and breathing. Factors such as increasing air pollution, exacerbating ailments like asthma, and an aging population, leading to more age-related diseases like COPD, are resulting in a higher occurrence of respiratory disorders. Poractant alfa is utilized to manage neonatal respiratory distress syndrome by augmenting lung function and aiding breathing in premature infants via an endotracheal tube. As per the National Asthma Council, an Australian non-profit entity, Australia recorded 467 asthma-related deaths in November 2023, marking a rise from the 355 fatalities recorded in 2021. This figure included 299 females and 168 males. Thus, the escalating instances of respiratory problems are fuelling the curosurf (poractant alfa) market's growth. The Curosurf (poractant alfa) market is also expected to benefit from an increasing rate of premature births. Premature births, defined as infants born before 37 weeks of gestation compared to a standard full-term pregnancy of about 40 weeks, is on the rise. This trend is related to older maternal age and the higher utilization of assisted reproductive technologies, which often result in multiple pregnancies. Poractant alfa aids in treating premature babies with respiratory distress syndrome by reducing lung surface tension, keeping the lungs open, and enhancing oxygen exchange. For example, according to the Office for National Statistics in the UK, the premature live birth rate in England and Wales rose to 7.9% in 2022, from 7.5% in 2021. Therefore, the growing instances of premature births are stimulating the growth of the Curosurf (poractant alfa) market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19893&type=smp

Who Are the Major Industry Players Fueling Curosurf (Poractant Alfa) Market Expansion?
Major companies operating in the curosurf (poractant alfa) market include Chiesi Farmaceutici S.p.A

Which Key Developments Are Influencing the Curosurf (Poractant Alfa) Market?
The curosurf (poractant alfa) market is predominantly focused on introducing innovative solutions such as new inhaled gene treatments to meet the demands of respiratory conditions. Inherited gene therapy is an emerging strategy that administers therapeutic genes straight to the lungs via inhalation, typically using aerosolized particles or nanoparticles. For instance, AlveoGene, a gene therapy developer based in the UK, received the Rare Pediatric Disease Designation (RPDD) by the FDA for AVG-002 in November 2024. AVG-002 is a unique inhaled gene therapy focusing on the deadly neonatal surfactant protein B (SP-B) shortage, a serious genetic disorder resulting in respiratory failure in newborns. The treatment options for SP-B deficiency, caused by mutations in the SFTPB gene, are presently limited, mostly depending on lung transplantation. AVG-002 uses AlveoGene's InGenuity platform to transport a functioning SP-B gene straight to the lungs, and it has shown encouraging results in early scientific trials.

How Is the Segmentation of the Curosurf (Poractant Alfa) Market Defined?
The curosurf (poractant alfa)market covered in this report is segmented -

1) By Type: Natural Poractant Alfa; Synthetic Poractant Alfa
2) By Sales Channel: Direct Sales; Distribution Channels; Online Marketplace
3) By Application: Pulmonary Edema; Respiratory Distress Syndrome; Other Respiratory Disorders
4) By End User: Hospitals; Clinics; Ambulance Services

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/curosurf-poractant-alfa-global-market-report-

What Is the Leading Region in the Curosurf (Poractant Alfa) Market?
North America was the largest region in the curosurf (poractant alfa) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the curosurf (poractant alfa) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Curosurf (Poractant Alfa) Global Market Report?

- Market Size Analysis: Analyze the curosurf (poractant alfa) Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the curosurf (poractant alfa) market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall curosurf (poractant alfa) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the curosurf (poractant alfa) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19893

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.